Skip to main content
Edward Kim, MD, Oncology, Charlotte, NC

Edward S. Kim MD MD, MBA, FACP, FASCO (He/Him)

Oncology•Charlotte, NC

Head & Neck Cancer, Thoracic Cancer

Senior Vice President & Vice Physician-in-Chief, City of Hope | Physician-in-Chief, City of Hope Orange County

Join to view full profile

  • 1021 Morehead Medical DrSte ACharlotte, NC 28204

  • Phone+1 980-442-2000

Dr. Kim is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Kim's full profileAlready have an account?

Education & Training

  • University of Texas Health Science Center at Houston/M D Anderson Cancer Center
    University of Texas Health Science Center at Houston/M D Anderson Cancer CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
  • Baylor College of Medicine
    Baylor College of MedicineResidency, Internal Medicine, 1996 - 1999
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1996

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2022 - 2028
  • TX State Medical License
    TX State Medical License 1998 - 2028
  • NC State Medical License
    NC State Medical License 2013 - 2026

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Stress Hormones Promote EGFR Inhibitor Resistance in NSCLC: Implications for Combinations with Β-blockers  
    Hai Tran, Anil K Sood, John V Heymach, Roy Herbst, Lecia V Sequist, Edward S Kim, Science Magazine

Lectures

  • Barriers to clinical trial accrual: Clinical trialists' perspectives. 
    2019 ASCO Annual Meeting - 6/1/2019
  • Phase 2 study of brigatinib in patients (pts) with anaplastic lymphoma kinase (ALK)-positive, advanced non-small cell lung cancer (NSCLC) that progressed on alectinib ... 
    2019 ASCO Annual Meeting - 6/1/2019
  • 94th Annual Meeting of American Radium Society 
    American Radium Society, Las Vegas, Nevada - 4/28/2012

Authored Content

  • Moving Away (Finally) from Doublet Therapy in Lung Cancer: Immunotherapy and KEYNOTE-189September 2018

Press Mentions

  • A Ribbon Cutting Full of ‘Hope’ Welcomes Orange County’s First Cancer Specialty Hospital
    A Ribbon Cutting Full of ‘Hope’ Welcomes Orange County’s First Cancer Specialty HospitalNovember 20th, 2025
  • City of Hope Opens Only Cancer Specialty Hospital in Orange County, Calif., Advancing a National Model for Cancer Research and Treatment
    City of Hope Opens Only Cancer Specialty Hospital in Orange County, Calif., Advancing a National Model for Cancer Research and TreatmentNovember 19th, 2025
  • City of Hope Prepares to See First Patients at Cancer Only Hospital
    City of Hope Prepares to See First Patients at Cancer Only HospitalNovember 17th, 2025

Grant Support

  • Personalizing NSCLC Therapy: Exploiting KRAS Activated PathwaysNIH/NCI2010–2015
  • U10 Full Member Application Affiliated with SWOGNIH/NCI2011–2012

Professional Memberships

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Edward Kim, Dr. Edward Kim, MD, Dr. E Kim, Dr. Edward S. Kim